Nalaganje...

The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications

Resistance to antiviral therapy is the limiting factor in the successful management of HIV. In general, the K65R mutation is rarely selected (1.7–4%) with tenofovir disoproxil fumarate (TDF), abacavir (ABC), didanosine (ddI), and stavudine (d4T), as compared with the high incidence (>40%) of thym...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Brenner, Bluma G, Coutsinos, Dimitrios
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826981/
https://ncbi.nlm.nih.gov/pubmed/20190870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hiv.09.40
Oznake: Označite
Brez oznak, prvi označite!